Inheritest® 14‑gene Panel
Also known as: Carrier screening, Expanded carrier testing, Pan-ethnic carrier screening
Use
This test is used for pan-ethnic carrier screening and includes disorders listed in the American College of Obstetricians and Gynecologists (ACOG) recommendations.
Special Instructions
Males are not tested for X‑linked disorders, including fragile X syndrome. Test orders must include an attestation that the provider has obtained the patient’s informed consent for genetic testing. ([womenshealth.labcorp.com](https://womenshealth.labcorp.com/tests/481797/inheritest-14-gene-panel?utm_source=openai))
Limitations
The technologies used do not detect germline mosaicism or large chromosomal aberrations, including rearrangements and gene fusions; they do not detect variants in regions or genes not included in this test or complex inter‑ or intragenic interactions. Repeat expansions are not reliably identified. Variant classification may change over time. False positive or negative results may occur due to rare variants, sex chromosome abnormalities, pseudogene interference, blood transfusions, bone marrow transplant, somatic or tissue‑specific mosaicism, sample mislabeling, or incorrect representation of family relationships. ([womenshealth.labcorp.com](https://womenshealth.labcorp.com/tests/481797/inheritest-14-gene-panel?utm_source=openai))
Methodology
NGS (Targeted)
Biomarkers
Mutation
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
8.5 mL
Minimum Volume
3 mL
Container
Yellow‑top (ACD‑A) tube or lavender‑top (EDTA) tube
Collection Instructions
Standard phlebotomy; Do not eat, drink, smoke or chew gum 30 minutes prior to collection.
Storage Instructions
Maintain specimen at room temperature or refrigerate at 4°C. Do not freeze.
Causes for Rejection
Frozen or hemolyzed specimen; quantity not sufficient; improper container; blood specimens more than four days post‑draw.